ArticleFrontiers in cardiovascular medicine2025
Sex differences in heart failure mortality by ejection fraction subtype: a single-center, retrospective cohort study.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Heart failure (HF) is a complex clinical syndrome characterized by structural or functional impairments in ventricular filling or ejection, leading to significant morbidity and mortality. This study investigates sex-specific differences in mortality across HF subtypes: heart failure with reduced ejection fraction (HFrEF), mildly reduced ejection fraction (HFmrEF), and preserved ejection fraction (HFpEF). Methods: A single-center, retrospective cohort study was conducted at the First Affiliated Hospital of Xinjiang Medical University, China, from August 16, 2012, to January 1, 2025. Patients diagnosed with HF based on the 2018 Chinese Guidelines for the Diagnosis and Treatment of Heart Failure were included. Data on demographics, clinical parameters, and HF subtypes were extracted. Cox proportional hazards regression models assessed all-cause mortality risk, with Kaplan-Meier analysis for survival curves. Results: Of 12,282 HF patients screened, 6,091 were included (median age: 69 years, IQR: 60-78). Females were older (median age: 72 vs. 67 years, Conclusions: Age is a significant independent risk factor for all-cause mortality in HF patients, with female sex emerging as a critical predictor in the HFmrEF subtype. These findings highlight the need for sex-specific risk stratification and tailored management strategies, particularly for females with HFmrEF. Future prospective, multi-center studies are needed to validate these results and explore underlying mechanisms to optimize HF outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.